Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT00514254

Risk Factors for Endometrial Cancer in Black Women

RATIONALE: Learning about the risk factors for endometrial cancer in black women may help the study of endometrial cancer in the future.

PURPOSE: This clinical trial is studying risk factors for endometrial cancer in black women.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

21 year and older

Sex eligibility

Female

Study type

Observational

Primary location

SUNY Downstate Medical Center, Brooklyn, New York, United States

Loading trial locations.

About this study

OBJECTIVES:

  • Establish and evaluate procedures for conducting a hospital-based case-control study of risk factors for endometrial cancer in black women.

OUTLINE: This is a multicenter study.

Participants complete questionnaires about lifestyle factors and their usual diet and measure their waist and hips. Saliva or buccal specimens are collected for future research.

PROJECTED ACCRUAL:

  • A total of 30 cases and 30 controls will be accrued for this study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

DISEASE CHARACTERISTICS:

  • Cases
  • Diagnosed with endometrial cancer within the past year
  • Self-identified as being black, African-American, black Hispanic, African, or Afro-Caribbean
  • Healthy controls
  • Self-identified as being black, African-American, black Hispanic, African, or Afro-Caribbean
  • No history of endometrial or other cancer (except non-melanoma skin cancer)
  • No prior hysterectomy

PATIENT CHARACTERISTICS:

  • Speak English
  • No medical condition that would make it difficult to complete the interview

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics

Treatment and study plan

Questionnaire Administration

Other

study of socioeconomic and demographic variables

Other

evaluation of cancer risk factors

Procedure

Primary outcomes

  1. Number and percentage of potential cases and controls approached who are found to be eligible for the study and reasons for being ineligible (including language)

    Time frame: 2 years

  2. Number and percentage of cases and controls approached who sign informed consent

    Time frame: 2 years

  3. Number and percentage of cases and controls who complete each part of the study (main questionnaire, diet questionnaire, saliva/buccal specimen)

    Time frame: 2 years

  4. Proportion of questions with missing data

    Time frame: 2 years

  5. Interviewer's evaluation of interview quality and respondent cooperation

    Time frame: 2 years

  6. Number and percentage of cases who are willing to have tumor specimens used for future research

    Time frame: 2 years

  7. Characteristics of cases and controls (demographics, main risk factors, and use of health care and screening)

    Time frame: 2 years

  8. Proportion of participants who rate the study positively on each measure in the post-interview assessment and respondents' suggested changes to the study

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Collaborators

  • DOWNSTATE MED/KINGS CO/BKLYN
  • Montefiore Medical Center
  • National Cancer Institute (NCI)
  • The City College of New York

Registry information

Official study title

Endometrial Cancer in Black Women

Important dates

Study start
2007
Primary completion
2026
Study completion
2026
First posted
Aug 9, 2007
Registry last updated
Aug 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.